Open label variable dose escitalopram (Lexapro) in the treatment of patients with postpartum major depression: a pilot study

Trial Profile

Open label variable dose escitalopram (Lexapro) in the treatment of patients with postpartum major depression: a pilot study

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Nov 2008

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Postnatal depression
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Nov 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 05 Nov 2008 Actual end date (Apr 2007) added as reported by ClinicalTrials.gov.
    • 24 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top